BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24784775)

  • 21. A Phase I Study Examining the Feasibility and Safety of an Aerobic Exercise Intervention in Patients With Rectal Cancer During and After Neoadjuvant Chemoradiotherapy.
    Morielli AR; Usmani N; Boulé NG; Tankel K; Severin D; Nijjar T; Joseph K; Courneya KS
    Oncol Nurs Forum; 2016 May; 43(3):352-62. PubMed ID: 27105196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
    Menon A; Abraham AG; Mahfouz M; Thachuthara JJ; Usmani N; Warkentin H; Ghosh S; Nijjar T; Severin D; Tankel K; Paulson K; Mulder K; Roa W; Joseph K
    Am J Clin Oncol; 2021 Sep; 44(9):487-494. PubMed ID: 34269694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiopulmonary exercise variables are associated with postoperative morbidity after major colonic surgery: a prospective blinded observational study.
    West MA; Lythgoe D; Barben CP; Noble L; Kemp GJ; Jack S; Grocott MP
    Br J Anaesth; 2014 Apr; 112(4):665-71. PubMed ID: 24322573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
    Svoboda M; Sana J; Fabian P; Kocakova I; Gombosova J; Nekvindova J; Radova L; Vyzula R; Slaby O
    Radiat Oncol; 2012 Nov; 7():195. PubMed ID: 23167930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.
    Yoon HI; Koom WS; Kim YB; Min BS; Lee KY; Kim NK; Shin SJ; Ahn JB; Keum KC
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):399-409. PubMed ID: 24390211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lower cut-off for lymph node harvest predicts for poorer overall survival after rectal surgery post neoadjuvant chemoradiotherapy.
    Yeo CS; Syn N; Liu H; Fong SS
    World J Surg Oncol; 2020 Mar; 18(1):58. PubMed ID: 32197615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficiency of pre-operative chemoradiotherapy in treating a case of advanced rectal cancer].
    Tamura A; Ami K; Watanabe A; Hayasaka J; Takagi K; Okamoto E; Kitazume A; Kondou M; Gokita K; Imai K; Tei S; Ando M; Arai K; Shibayama T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1566-8. PubMed ID: 25731254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is restaging with chest and abdominal CT scan after neoadjuvant chemoradiotherapy for locally advanced rectal cancer necessary?
    Ayez N; Alberda WJ; Burger JW; Eggermont AM; Nuyttens JJ; Dwarkasing RS; Willemssen FE; Verhoef C
    Ann Surg Oncol; 2013 Jan; 20(1):155-60. PubMed ID: 22875644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capecitabine as a radiosensitizing agent in neoadjuvant treatment of locally advanced resectable rectal cancer: prospective phase II trial.
    Velenik V; Anderluh F; Oblak I; Strojan P; Zakotnik B
    Croat Med J; 2006 Oct; 47(5):693-700. PubMed ID: 17042060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical activity programmes for patients undergoing neo-adjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis.
    Latrille M; Buchs NC; Ris F; Koessler T
    Medicine (Baltimore); 2021 Dec; 100(51):e27754. PubMed ID: 34941028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemoradiotherapy with capecitabine followed by laparoscopic resection in locally advanced tumors of middle and low rectum - toxicity and complications of the treatment.
    Soumarova R; Skrovina M; Bartos J; Gruna J; Wendrinski A; Czudek S; Kycina R; Parvez J
    Eur J Surg Oncol; 2010 Mar; 36(3):251-6. PubMed ID: 19879716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients.
    Osti MF; Agolli L; Bracci S; Masoni L; Valeriani M; Falco T; De Sanctis V; Maurizi Enrici R
    Int J Colorectal Dis; 2014 Jul; 29(7):835-42. PubMed ID: 24825722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicentre cohort study assessing the utility of routine blood tests as adjuncts to identify complete responders in rectal cancer following neoadjuvant chemoradiotherapy.
    Eastern Rectal Cancer Response Collaborative, Ireland
    Int J Colorectal Dis; 2022 Apr; 37(4):957-965. PubMed ID: 35325271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study.
    Knight KA; Drami I; McMillan DC; Horgan PG; Park JH; Jenkins JT; Roxburgh CSD
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3409-3420. PubMed ID: 33710416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-operative chemoradiotherapy with oral capecitabine in locally advanced, resectable rectal cancer.
    Korkolis DP; Boskos CS; Plataniotis GD; Gontikakis E; Karaitianos IJ; Avgerinos K; Katopodi A; Xinopoulos D; Dimitroulopoulos D; Beroukas K; Vassilopoulos PP
    Anticancer Res; 2007; 27(1B):541-5. PubMed ID: 17348439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
    Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
    Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer.
    González-González M; Garcia J; Alcazar JA; Gutiérrez ML; Gónzalez LM; Bengoechea O; Abad MM; Santos-Briz A; Blanco O; Martín M; Rodríguez A; Fuentes M; Muñoz-Bellvis L; Orfao A; Sayagues JM
    Medicine (Baltimore); 2014 Nov; 93(26):e153. PubMed ID: 25474426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
    Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
    Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of preoperative chemoradiotherapy on changes of epidermal growth factor receptor expression in patients treated by preoperative chemoradiotherapy for local advanced rectal carcinoma].
    Richter I; Dvořák J; Blüml A; Cermáková E; Bartoš J; Urbanec M; Sitorová V; Ryška A; Sirák I; Buka D; Ferko A; Melichar B; Petera J
    Klin Onkol; 2014; 27(5):361-6. PubMed ID: 25312714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic Impact of Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Low Rectal Cancer Treated with Preoperative Chemoradiotherapy.
    Nagasaki T; Akiyoshi T; Fujimoto Y; Konishi T; Nagayama S; Fukunaga Y; Ueno M
    Dig Surg; 2015; 32(6):496-503. PubMed ID: 26544755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.